Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-8744
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients ; day:14 ; month:6 ; year:2016 ; pages:1-13
Journal of pharmacokinetics and pharmacodynamics ; (14.6.2016), 1-13
- Creator
-
Hang, Yaming
- Contributor
-
Hu, Xiao
Zhang, Jie
Liu, Shifang
Deykin, Aaron
Nestorov, Ivan
SpringerLink (Online service)
- DOI
-
10.1007/s10928-016-9477-x
- URN
-
urn:nbn:de:1111-201606176008
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hang, Yaming
- Hu, Xiao
- Zhang, Jie
- Liu, Shifang
- Deykin, Aaron
- Nestorov, Ivan
- SpringerLink (Online service)
Other Objects (12)
Relapsing/remitting type 1 diabetes
An algorithm strategy for precise patient monitoring in a connected healthcare enterprise
White matter lesion load and location in relation to cognitive impairment in relapsing–remitting multiple sclerosis
Quantitative T 1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study
Instance and Output Optimal Parallel Algorithms for Acyclic Joins
Relapsing/remitting type 1 diabetes
An algorithm strategy for precise patient monitoring in a connected healthcare enterprise
White matter lesion load and location in relation to cognitive impairment in relapsing–remitting multiple sclerosis
Quantitative T 1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study
Instance and Output Optimal Parallel Algorithms for Acyclic Joins
Relapsing/remitting type 1 diabetes
An algorithm strategy for precise patient monitoring in a connected healthcare enterprise
White matter lesion load and location in relation to cognitive impairment in relapsing–remitting multiple sclerosis
Quantitative T 1 brain mapping in early relapsing-remitting multiple sclerosis: longitudinal changes, lesion heterogeneity and disability
Postural Control in Relapsing-Remitting Multiple Sclerosis
Endocarditis following ocrelizumab in relapsing-remitting MS
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations
Relapsing–remitting painful ophthalmoplegia due to orbital myositis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study